Home » Topics » Regulatory » Patents

Patents
RSS

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Sep. 10, 1997

Bayer discloses inhibitors of leukotriene synthesis

Sep. 10, 1997

RPR discloses new factor Xa inhibitors

Sep. 10, 1997

Tachykinin receptor antagonists developed at Janssen

Sep. 10, 1997

Osteoprotegerin: new polypeptide for bone diseases

Sep. 9, 1997

Warner-Lambert/CoCensys develop neuroprotective agents

Sep. 9, 1997

Agents useful for BPH from Pfizer

Sep. 9, 1997

Celltech prepares improved PDE IV inhibitors

Sep. 8, 1997

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

New antiandrogenic compounds prepared at Roussel Uclaf

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...